Skip to content

Search for biomarkers related to Operational Tolerance in living-donor liver transplant patients

Search for biomarkers related to Operational Tolerance in living-donor liver transplant patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030220500
Enrollment
140
Registered
2022-12-09
Start date
2023-06-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients (and their donors) who have undergone living-donor liver transplantation and are scheduled

Interventions

None listed

Sponsors

Uchida Koichiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [Recipient selection criteria] 1) Among patients who have undergone living-donor liver transplantation, those who are scheduled to undergo liver biopsy 2) A person who has voluntarily obtained written consent from the person or his / her substitute for participation in this research. [Donor selection criteria] 1) Recipients whose organs have been donated by themselves have given written consent to participate in this study. 2) Who have obtained free and voluntary written consent for participation in this study from the recipient.

Exclusion criteria

Exclusion criteria: 1) Patients who are considered difficult to carry out this study by the principal inverstigator,ect.

Design outcomes

Primary

MeasureTime frame
1.Liver histopathological findings 2.Expression of tolerant/inflammatory cells in peripheral blood 3.Expression distribution and intensity of tolerant/inflammatory cells in the graft 4.Expression level of inflammatory/inhibitory molecule/cytokine genes in the graft 5.Expression level of inflammatory/inhibitory molecule/cytokine genes in lymphocytes infitrating into the graft 6.Evaluation of immune anti-donor responsiveness(CD4+T cell,CD8+T cell division ability)

Contacts

Public ContactSaori Hirota

Juntendo University

jb101juntendo@gmail.com+81-3-3811-1881

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026